Asosiy kontentga oʻtish
Boshqa

Peer Review Report For: Laboratory-Based Retrospective Study on ANA Profile Results in Ajman: A Decade of Autoantibody Distribution by Age and Gender [version 1; peer review: 1 approved with reservations]

Sara Mohammed AliDepartment of Medical Laboratory Sciences, Gulf Medical University, AjmanMarwan IsmailDepartment of Medical Laboratory Sciences, Gulf Medical University, AjmanAbdelgadir ElaminDepartment of Medical Laboratory Sciences, Gulf Medical University, AjmanSalah OmerDepartment of Medical Laboratory Sciences, Gulf Medical University, AjmanAhmed L. OsmanDepartment of Medical Laboratory Sciences, Gulf Medical University, AjmanSalma E R MohamedDepartment of Medical Laboratory Sciences, Gulf Medical University, AjmanFatema T. ElgengehyRheumatology Department, Cairo university faculty of medicine, CairoFayzullayev Dilshod ShodievichDepartment of Otorhinolaryngology, Faculty of Postgraduate Education, Samarkand State University, SamarkandShawgi A. ElsiddigClinical Laboratory Sciences Department, Jouf University College of Applied Medical Sciences, SakakaGamila Ali AttaelmananMedical Laboratory Sciences, Hematology department, Al-neelain university, KhartoumMudathir Abdelshafea Abdelkareem AbakarDepartment of Microbiology and Immunology, Faculty Of Medical Laboratory Sciences, Alzaiem Alazhari University, Khartoum, KhartoumAji GopakumarData and Statistics Department, Emirates Health Services, Dubai
2026
Ochiq kirishOltin

Litsenziya: cc-by

ABI

Annotatsiya

Background Antinuclear antibodies (ANA) are vital in diagnosing and monitoring autoimmune diseases, with prevalence affected by demographics and environment. Aim This study analyzed ANA testing trends over a decade in Ajman, UAE, focusing on prevalence, antibody types, and demographics, filling a gap in Middle Eastern longitudinal data. Methods A retrospective, cross-sectional examination of Thumbay Labs ANA profile data from 2015 to 2025 was performed. HEp-2 cell–based indirect immunofluorescence assays were run first, followed by extractable nuclear antigen testing. In addition to age and gender, autoantibody patterns were collected. While descriptive statistics summarized prevalence, chi-square tests examined associations. Logistic regression models estimated independent ANA-positive predictor ORs and 95% CIs. Results Among 2,482 individuals tested (67.6% female), 30.7% demonstrated positivity for at least one ANA-related antibody. Anti-Ro52 (7.9%), anti-SSA/Ro (7.2%), and anti-RNP/Sm (4.3%) were the most frequently detected autoantibodies. Females exhibited significantly higher ANA positivity than males (33.1% vs. 23.1%; p < 0.001). Gender remained an independent predictor in multivariable analysis (OR = 1.42; 95% CI: 1.18–1.72), with females also showing increased odds of anti-Ro52, anti-SSA/Ro, anti-SSB/La, and anti-histone reactivity. Although age demonstrated variability in univariate analyses, it did not independently predict ANA positivity. Conclusions Our study results align with international trends and provide the first decade-long summary of ANA testing patterns in the UAE. The data establish a baseline for autoimmune disease surveillance and highlight the need for clinical–laboratory coordination and prospective studies to understand ANA reactivity in this location further.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar

0 ta iqtibos0 ta foydalanilgan manba